301 related articles for article (PubMed ID: 28424989)
21. Mobilization of CD4+ T lymphocytes in inflamed mucosa reduces pain in colitis mice: toward a vaccinal strategy to alleviate inflammatory visceral pain.
Basso L; Boué J; Augé C; Deraison C; Blanpied C; Cenac N; Lluel P; Vergnolle N; Dietrich G
Pain; 2018 Feb; 159(2):331-341. PubMed ID: 29140925
[TBL] [Abstract][Full Text] [Related]
22. IL-2 is positively involved in the development of colitogenic CD4+ IL-7R alpha high memory T cells in chronic colitis.
Kameyama K; Nemoto Y; Kanai T; Shinohara T; Okamoto R; Tsuchiya K; Nakamura T; Sakamoto N; Totsuka T; Hibi T; Watanabe M
Eur J Immunol; 2010 Sep; 40(9):2423-36. PubMed ID: 20623548
[TBL] [Abstract][Full Text] [Related]
23. Proteinase-activated receptor-1 is an anti-inflammatory signal for colitis mediated by a type 2 immune response.
Cenac N; Cellars L; Steinhoff M; Andrade-Gordon P; Hollenberg MD; Wallace JL; Fiorucci S; Vergnolle N
Inflamm Bowel Dis; 2005 Sep; 11(9):792-8. PubMed ID: 16116312
[TBL] [Abstract][Full Text] [Related]
24. The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice.
Nishida A; Lau CW; Zhang M; Andoh A; Shi HN; Mizoguchi E; Mizoguchi A
Gastroenterology; 2012 Apr; 142(4):865-874.e2. PubMed ID: 22202458
[TBL] [Abstract][Full Text] [Related]
25. Regulation of T cell lineage commitment by SMAR1 during inflammatory & autoimmune diseases.
Mirlekar B; Majumdar S; Khetmalas M; Chattopadhyay S
Indian J Med Res; 2015 Oct; 142(4):405-13. PubMed ID: 26609032
[TBL] [Abstract][Full Text] [Related]
26. TLR2 Involved in Naive CD4+ T Cells Rescues Stress-Induced Immune Suppression by Regulating Th1/Th2 and Th17.
Zhao J; Liu J; Denney J; Li C; Li F; Chang F; Chen M; Yin D
Neuroimmunomodulation; 2015; 22(5):328-36. PubMed ID: 25721027
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
[TBL] [Abstract][Full Text] [Related]
28. TGF-β converts Th1 cells into Th17 cells through stimulation of Runx1 expression.
Liu HP; Cao AT; Feng T; Li Q; Zhang W; Yao S; Dann SM; Elson CO; Cong Y
Eur J Immunol; 2015 Apr; 45(4):1010-8. PubMed ID: 25605286
[TBL] [Abstract][Full Text] [Related]
29. Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice.
Siegmund B; Sennello JA; Jones-Carson J; Gamboni-Robertson F; Lehr HA; Batra A; Fedke I; Zeitz M; Fantuzzi G
Gut; 2004 Jul; 53(7):965-72. PubMed ID: 15194645
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of the effects of anti-IL-6 receptor mAb and anti-TNF mAb treatment on CD4+ T-cell responses in murine colitis.
Terabe F; Fujimoto M; Serada S; Shinzaki S; Iijima H; Tsujii M; Hayashi N; Nomura S; Kawahata H; Jang MH; Miyasaka M; Mihara M; Ohsugi Y; Kishimoto T; Naka T
Inflamm Bowel Dis; 2011 Feb; 17(2):491-502. PubMed ID: 20602470
[TBL] [Abstract][Full Text] [Related]
31. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation.
Asseman C; Mauze S; Leach MW; Coffman RL; Powrie F
J Exp Med; 1999 Oct; 190(7):995-1004. PubMed ID: 10510089
[TBL] [Abstract][Full Text] [Related]
32. Dietary n-3 polyunsaturated fatty acids (PUFA) decrease obesity-associated Th17 cell-mediated inflammation during colitis.
Monk JM; Hou TY; Turk HF; Weeks B; Wu C; McMurray DN; Chapkin RS
PLoS One; 2012; 7(11):e49739. PubMed ID: 23166761
[TBL] [Abstract][Full Text] [Related]
33. Sodium selenite ameliorates dextran sulfate sodium-induced chronic colitis in mice by decreasing Th1, Th17, and γδT and increasing CD4(+)CD25(+) regulatory T-cell responses.
Sang LX; Chang B; Zhu JF; Yang FL; Li Y; Jiang XF; Wang DN; Lu CL; Sun X
World J Gastroenterol; 2017 Jun; 23(21):3850-3863. PubMed ID: 28638225
[TBL] [Abstract][Full Text] [Related]
34. CD4+CD25+ regulatory T cells suppress Th17-responses in an experimental colitis model.
Ogino H; Nakamura K; Ihara E; Akiho H; Takayanagi R
Dig Dis Sci; 2011 Feb; 56(2):376-86. PubMed ID: 20521112
[TBL] [Abstract][Full Text] [Related]
35. Regulation of gut inflammation and th17 cell response by interleukin-21.
Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
[TBL] [Abstract][Full Text] [Related]
36. Regulatory T cells suppress development of colitis, blocking differentiation of T-helper 17 into alternative T-helper 1 cells.
Sujino T; Kanai T; Ono Y; Mikami Y; Hayashi A; Doi T; Matsuoka K; Hisamatsu T; Takaishi H; Ogata H; Yoshimura A; Littman DR; Hibi T
Gastroenterology; 2011 Sep; 141(3):1014-23. PubMed ID: 21699791
[TBL] [Abstract][Full Text] [Related]
37. TOB1 Blocks Intestinal Mucosal Inflammation Through Inducing ID2-Mediated Suppression of Th1/Th17 Cell Immune Responses in IBD.
Lin R; Ma C; Fang L; Xu C; Zhang C; Wu X; Wu W; Zhu R; Cong Y; Liu Z
Cell Mol Gastroenterol Hepatol; 2022; 13(4):1201-1221. PubMed ID: 34920145
[TBL] [Abstract][Full Text] [Related]
38. Immunosenescent colitogenic CD4(+) T cells convert to regulatory cells and suppress colitis.
Totsuka T; Kanai T; Nemoto Y; Tomita T; Tsuchiya K; Sakamoto N; Okamoto R; Watanabe M
Eur J Immunol; 2008 May; 38(5):1275-86. PubMed ID: 18412161
[TBL] [Abstract][Full Text] [Related]
39. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.
Radulovic K; Manta C; Rossini V; Holzmann K; Kestler HA; Wegenka UM; Nakayama T; Niess JH
J Immunol; 2012 Feb; 188(4):2001-13. PubMed ID: 22250092
[TBL] [Abstract][Full Text] [Related]
40. Immune conditions associated with CD4+ T effector-induced opioid release and analgesia.
Boué J; Blanpied C; Djata-Cabral M; Pelletier L; Vergnolle N; Dietrich G
Pain; 2012 Feb; 153(2):485-493. PubMed ID: 22188867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
